Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zahravi Pharmaceutical Company, based in Tabriz, Iran, is a leading manufacturer of specialized pharmaceutical products, particularly known for its expertise in soft gelatin capsule technology. Founded in 1991, the company produces a wide range of medications including immunosuppressants for transplant patients, oncology treatments, and biotechnological products like recombinant proteins. Zahravi is a key player in the Middle Eastern pharmaceutical market and is a subsidiary of the Tamin Pharmaceutical Investment Company (TPICO). Its portfolio includes well-known brands for treating chronic conditions such as multiple sclerosis and kidney disease. The company is listed on the Tehran Stock Exchange and maintains high-standard manufacturing facilities that comply with international GMP guidelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zahravey Company.